Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions

AstraZeneca

Status: Completed

Conditions: Gastrointestinal Diseases

Study type: Observational

Funder types: Industry

Identifiers

NCT00612027

1312004011

German PMS trial no.9

Details and patient eligibility

About

Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e. general practitioners and internists) are asked to document relevant data related to esomeprazole therapy in patients with gastrointestinal disorders. Patients with acid associated gastrointestinal symptoms can be included.

Enrollment: 29,586 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with gastrointestinal disorders and patients with acid associated gastrointestinal symptoms treated with esomeprazole.

Exclusion criteria

• limitiations; possible risks; warnings; contraindications mentioned in the SPC.

Trial design

29,586 participants in 1 patient group

1

Description:

patients with gastrointestinal disorders and patients with acid associated gastrointestinal symptoms treated with esomeprazole.